Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Oregon Research Institute |
---|---|
Information provided by: | Oregon Research Institute |
ClinicalTrials.gov Identifier: | NCT00680381 |
The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.
Condition | Intervention | Phase |
---|---|---|
Substance Abuse |
Behavioral: MTI, Minimal Transitional Intervention Behavioral: GTI, Group Transitional Intervention Behavioral: STI, Systems Transitions Intervention |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | Transitional Treatment of Adolescents in Family Therapy |
Estimated Enrollment: | 90 |
Study Start Date: | January 2004 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly therapist phone calls for eight weeks.
|
Behavioral: MTI, Minimal Transitional Intervention
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
|
2: Active Comparator
Following 12 weeks of FFT, weekly one-hour group therapy for eight weeks
|
Behavioral: GTI, Group Transitional Intervention
Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
|
3: Active Comparator
Following 12 weeks of FFT, an eight-week, customized series of therapist visits with the adolescent, family, teachers, coaches and others who can support the adolescent's reduced level of drug use.
|
Behavioral: STI, Systems Transitions Intervention
Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.
|
Ages Eligible for Study: | 13 Years to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Betsy Morrison, B.A. | 505 842-8932 ext 103 | betsym@ori.org |
Contact: Timerie Nastav, B.A. | 505 842-8932 ext 101 | timerien@ori.org |
United States, New Mexico | |
Oregon Res. Inst. Center for Family & Adolescent Research (CFAR) | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Betsy Morrison, B.A. 505-842-8932 ext 103 betsym@ori.org | |
Contact: Timerie Nastav, B.A. 505 842-8932 ext 101 timerien@ori.org | |
Sub-Investigator: Janet L Brody, Ph.D. | |
Principal Investigator: Holly B Waldron, Ph.D. |
Principal Investigator: | Holly B. Waldron, Ph.D. | Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR) |
Responsible Party: | Oregon Research Institute ( Holly B. Waldron, Ph.D. ) |
Study ID Numbers: | DA15762, R01DA15762 |
Study First Received: | May 16, 2008 |
Last Updated: | November 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00680381 |
Health Authority: | United States: Institutional Review Board |
adolescent substance abuse |
Mental Disorders Substance-Related Disorders Disorders of Environmental Origin |